Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Conditions:   Esophageal Cancer;   Biliary Tract Cancer;   GastroEsophageal Cancer;   Hepatobiliary Neoplasm
Interventions:   Drug: DKN-01;   Drug: Atezolizumab;   Drug: Paclitaxel
Sponsors:   European Organisation for Research and Treatment of Cancer - EORTC;   Hoffmann-La Roche;   Leap Therapeutics, Inc.
Not yet recruiting

http://bit.ly/2HLy7uO